イスラエルで最高の生検医師 - トップ40名の医師

この医師は、インドのグルガオンにあるMedanta - The Medicityで、主要な心臓専門医であり、インターベンショナル心臓病学の会長です。彼は、インドでRotarexやKensey Nash DPDのような新しいデバイスの使用を先駆けたことで知られています。<\/p>

彼は年間2500以上の診断手順と2000の経皮的介入を行っており、バルブ形成術も含まれます。彼はインドの血管内介入学会およびアジア太平洋インターベンショナル心臓病学会のフェローです。<\/p>

彼は主要な医学雑誌に100以上の記事を執筆しており、2016年には医学における模範的な業績に対してPadma Shri賞を受賞しました。<\/p>

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Alon Friedlander, MD, is an orthopedic surgeon and a spine and scoliosis specialist for adults and children. He is the Director of the Orthopedic Department at Sheba Medical Center. He is also an Associate Professor of Orthopedics at Tel Aviv University. He is listed by Forbes among Israel’s Top Doctors.

He treats complex spine disorders with minimally invasive and open surgery. His procedures include anterior and posterior fixation. His focus areas are scoliosis and other deformities, tumors, stenosis and instability, and disc herniation. Education: MD, Tel Aviv University; residency, Sheba Medical Center. Fellowships: Institut Mutualiste Montsouris and University Hospitals of Strasbourg (France); Queen Mary Hospital and the Duchess of Kent Children’s Hospital (Hong Kong).

Advisory roles: IDF referral physician. Consultant to soccer teams. Specialist for the Spartak Basketball Club (knee injuries).

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

アリ・ラファエル教授――テルアビブ・スラスキー医療センター（イキロフ、テルアビブ）トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。

資格および患者への貢献：

• 腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。

• 主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。

• 米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。

• 国際学術団体の会員（ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association）。最新の治療基準を活用し、国際的な研究に参画しています。

• 　ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。

ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。

シボレト博士は、50年以上の実践経験を持つイスラエルのトップの消化器病専門医であり、血液学者です。彼はイヒロヴ医療センターのデータによれば、イスラエルの肝臓の専門家として知られています。

専門分野

オレン・シボレト博士の主な専門分野は肝疾患の治療です。彼は、慢性肝炎や自己免疫、遺伝性肝疾患のような重篤な場合でも、肝臓のあらゆる病理の治療と診断を提供しています。

職務経歴

• スルアスキ（イヒロヴ）医療センターの肝臓科の責任者。

学歴

• ヘブライ大学医学部 — 一般医学の学位
• ヘブライ大学ハダッサ医科大学校 — 消化器学の専門。

科学活動

シボレト博士は肝疾患の研究を行っており、60を超える出版物と100の会議要旨の著者です。

組織への所属

• イスラエル消化器病学会
• アメリカ消化器学会
• ヨーロッパ肝臓研究会議
• アメリカ肝疾患学会。

Dr. Michael Shapira is an experienced Bone Marrow Transplantation specialist, who speaks English and Hebrew, and graduated from the Hebrew university medical school in 1999.

• Specializes in Bone Marrow Transplantation
• Speaks English and Hebrew
• Graduated from Hebrew university medical school in 1999
• Specialized in internal medicine in Hadassah medical center
• Joined Bone Marrow Transplantation department in Hadassah as a senior physician

Dr. Yigal Volman is a highly experienced and respected Israeli obstetrician and gynecologist who has 25 years of experience and is affiliated with numerous medical societies. He is currently an obstetrician at Tel Aviv Sourasky Hospital and professor of gynecology at the faculty of medicine of Tel Aviv University. He has published 80 scientific articles in medical journals and has 11 textbook chapters.

ダン・グリサロ教授は、婦人科がんの診断と治療においてイスラエルの第一人者です（卵巣がん、子宮がん、子宮頸がん）。

教授は、子宮頸がんの原因特定、および卵巣がんの診断のための鼠径リンパ節の分析を通じて、早期マーカーの研究とターゲット治療の特定に関する研究を行っています。

経験:

• イキロベ・ソラスキー医療センターの婦人科腫瘍学部門における上級医師;
• イキロベ・ソラスキー医療センターの産科婦人科部門の部長。

学歴:

• テルアビブ大学、教授、婦人科及び産科部門;
• トロント大学（カナダ）、婦人科腫瘍学専攻;
• エルサレムのヘブライ大学医学部、「産科および婦人科」専攻。

学術経験:

2011年以降。テルアビブ大学医学部の上級講師; テルアビブ大学産科婦人科部門の准教授。

科学活動と出版物:

ダン・グリサロ教授は科学会議で39の発表を行い、さまざまな専門誌に83の科学論文を著しています。

組織での会員:

• イスラエル産婦人科医協会;
• イスラエル婦人科腫瘍学協会;
• 米国婦人科腫瘍学会;
• カナダ婦人科腫瘍学会。

ガルズ・オスナット医師は、一般および泌尿器婦人科の最高カテゴリの専門家であり、婦人科の分野で活躍する医師であり教授です。彼の資格のハイライトは以下の通りです：

• MD、PhD - 医学博士。
• テルアビブ大学のサックラー医学部を優秀な成績で卒業しました。
• イスラエルのテルアビブにあるソラスキークリニックで婦人科および産科の専門家として専門性を高めました。
• アメリカ、ニューヨーク病院でブラヴァス教授の指導の下、婦人科学の臨床研究に参加しました。
• テルアビブ医療センターのリス産科病院で婦人科部門の主任医師を務めました。
• マッカビクリニックで独立した婦人科医として働きました。
• リス産科病院およびアスータ病院、アヤMCでシニアマテリアルアナリストとして活動しました。
• テルアビブ大学医学部産科婦人科クリニカル教授。
• アメリカ、ニューヨークでの婦人科学の研究に参加したほか、自国内でも他の科学的および臨床的研究に従事しました。

この医師は、低侵襲手術およびロボット手術において豊富な経験を持つ、ボード認定の外科医です。これらの先進的な外科技術を専門とし、Sourasky Medical Centerで診療を行い、患者の治療結果を改善するためにその専門知識を活用しています。

ジャック・バニエル教授は、イスラエルのペタハ・ティクヴァにあるラビンメディカルセンターの泌尿器科教授であり、泌尿器科セクションの主任です。彼は膀胱の再建、ロボット支援による前立腺切除術、神経終末の保存を伴うがん手術を行います。彼はベイリソン病院における腫瘍泌尿器科部門の創設者です。

彼は100本以上の科学論文を発表しています。ジャック・バニエル教授は泌尿器腫瘍学に関する最大の出版物のアナリストであり、グローバル規模の臨床研究に参加しています。また、彼はワイツマン科学研究所およびテルアビブ大学の研究者グループに所属しており、泌尿器腫瘍学の分野での臨床研究を担う国際的な研究組織の理事を務めています。

教育:

テルアビブ大学。

専門組織への所属:

• イスラエル医学会。
• イスラエル泌尿器科学会。
• ヨーロッパ泌尿器科学会。
• 欧州癌研究治療機構（EORTC）。
• 米国泌尿器科学会。